| Text of Recommendation | The Under Secretary for Health evaluates the need for conducting research on the use of ketamine and esketamine for treatment-resistant depression including the comparative efficacy of ketamine and esketamine, the effect of route of administration, therapeutic dose range, mechanism of action, and efficacy and safety of long-term treatment, and initiates research efforts as indicated. |
|---|---|
| Recommendation Number | 2 |
| Recommendation Status | Closed |
| Significant Recommendation | Yes |
| Recommendation Questioned Costs | $0 |
| Recommendation Funds for Better Use | $0 |
| Submitting OIG | |
|---|---|
| Report Title | Deficiencies in Coordination of Care for Patients with Treatment-Resistant Depression at the VA San Diego Healthcare System in California |
| Report Submitting OIG-Specific Report Number | 20-03359-220 |
| Report Date Issued | Tuesday, August 24, 2021 |
| Report Agency Reviewed / Investigated | |
| Report Questioned Costs | $0 |
| Report Funds for Better Use | $0 |